title: Excess bone marrow B-cells in patients with multiple myeloma achieving complete remission following autologous stem cell transplantation is a biomarker for improved survival.
authors.forename: Elizabeth
authors.initials: E
authors.lastname: Byrne
authors.forename: Kikkeri N
authors.initials: KN
authors.lastname: Naresh
authors.forename: Chrissy
authors.initials: C
authors.lastname: Giles
authors.forename: Amin
authors.initials: A
authors.lastname: Rahemtulla
mesh_terms: D000328:Adult; D000368:Aged; D001402:B-Lymphocytes / Q000276:immunology / Q000473:pathology*; D014408:Biomarkers, Tumor; D001854:Bone Marrow Cells / Q000276:immunology / Q000473:pathology*; D005260:Female; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D053208:Kaplan-Meier Estimate; D008297:Male; D008875:Middle Aged; D009101:Multiple Myeloma / Q000276:immunology / Q000473:pathology* / Q000601:surgery*; D016019:Survival Analysis
chemical_list: D014408:Biomarkers, Tumor